Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ASLN |
---|---|---|
09:32 ET | 20862 | 0.4 |
09:38 ET | 1000 | 0.43 |
09:41 ET | 1000 | 0.42 |
09:43 ET | 830 | 0.4001 |
09:45 ET | 100 | 0.417 |
09:48 ET | 2400 | 0.417 |
10:15 ET | 200 | 0.414835 |
10:19 ET | 218 | 0.416493 |
10:33 ET | 200 | 0.417 |
11:15 ET | 2328 | 0.4003 |
11:33 ET | 1805 | 0.4 |
11:36 ET | 12490 | 0.4003 |
11:47 ET | 3700 | 0.4001 |
11:56 ET | 100 | 0.400843 |
12:12 ET | 12304 | 0.3939 |
12:16 ET | 5080 | 0.391 |
12:18 ET | 23711 | 0.391 |
12:20 ET | 500 | 0.383 |
12:27 ET | 5400 | 0.3831 |
12:30 ET | 250 | 0.3872 |
12:34 ET | 100 | 0.385 |
12:36 ET | 200 | 0.3851 |
12:38 ET | 5300 | 0.3835 |
12:41 ET | 100 | 0.3836 |
12:43 ET | 11933 | 0.3836 |
12:45 ET | 3250 | 0.383 |
12:52 ET | 7510 | 0.381 |
12:54 ET | 3100 | 0.3811 |
12:56 ET | 715 | 0.385451 |
12:59 ET | 653 | 0.385 |
01:06 ET | 19406 | 0.377799 |
01:08 ET | 1432 | 0.3769 |
01:10 ET | 1500 | 0.3771 |
01:14 ET | 100 | 0.377 |
01:15 ET | 1200 | 0.3835 |
01:39 ET | 3100 | 0.385 |
01:46 ET | 7982 | 0.38 |
02:02 ET | 100 | 0.38 |
02:06 ET | 240 | 0.38 |
02:15 ET | 2000 | 0.377 |
02:29 ET | 19996 | 0.37 |
02:31 ET | 8573 | 0.366 |
02:33 ET | 21050 | 0.3532 |
02:36 ET | 23014 | 0.3463 |
02:38 ET | 2136 | 0.3451 |
02:40 ET | 7218 | 0.351 |
02:42 ET | 1114 | 0.3628 |
02:44 ET | 12170 | 0.3697 |
02:45 ET | 1000 | 0.3649 |
02:49 ET | 8200 | 0.3698 |
02:54 ET | 600 | 0.3698 |
02:58 ET | 1200 | 0.369699 |
03:00 ET | 500 | 0.3697 |
03:02 ET | 1000 | 0.364949 |
03:16 ET | 100 | 0.3651 |
03:20 ET | 5764 | 0.3601 |
03:21 ET | 100 | 0.3689 |
03:39 ET | 600 | 0.3768 |
03:43 ET | 300 | 0.3626 |
03:48 ET | 1000 | 0.36425 |
03:57 ET | 2750 | 0.3642 |
03:59 ET | 300 | 0.3601 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Aslan Pharmaceuticals Ltd | 9.3M | -0.1x | --- |
Moleculin Biotech Inc | 9.6M | -0.3x | --- |
Protext Mobility Inc | 8.8M | 0.0x | --- |
Nymox Pharmaceutical Corp | 8.4M | -2.1x | --- |
Kintara Therapeutics Inc | 10.1M | 0.0x | --- |
Enzolytics Inc | 8.3M | 0.0x | --- |
ASLAN Pharmaceuticals Limited is a clinical-stage immunology focused biopharmaceutical company. The Company's portfolio is led by eblasakimab (ASLAN004), a potential human monoclonal antibody that binds to the IL-13 receptor a1 subunit (IL-13Ra1), blocking signaling of two pro-inflammatory cytokines, IL-4 and IL-13, which are central to triggering symptoms of atopic dermatitis, such as redness and itching of the skin. It is conducting a Phase II b clinical trial investigating eblasakimab as a therapeutic antibody for moderate-to-severe atopic dermatitis (AD). The Company is also developing farudodstat (ASLAN003), an orally active, potent inhibitor of human dihydroorotate dehydrogenase (DHODH) that has the potential to be a therapy for autoimmune disease. The Company is also focused on developing antagonists of the aryl hydrocarbon receptor (AhR), an immune checkpoint inhibitor, through a joint venture.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.3M |
---|---|
Revenue (TTM) | $12.0M |
Shares Outstanding | 905.1K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.44 |
EPS | $-3.01 |
Book Value | $3.00 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 0.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -369.02% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.